ID   NAN-11
AC   CVCL_WR55
SY   NAN11
DR   Cosmic; 2809786
DR   Wikidata; Q95992151
RX   PubMed=30545397;
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,11; B*13,27; C*02,06 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
RX   PubMed=30545397; DOI=10.1186/s13045-018-0679-0; PMCID=PMC6293660;
RA   Tessoulin B., Moreau-Aubry A., Descamps G., Gomez-Bougie P., Maiga S.,
RA   Gaignard A., Chiron D., Menoret E., Le Gouill S., Moreau P., Amiot M.,
RA   Pellat-Deceunynck C.;
RT   "Whole-exon sequencing of human myeloma cell lines shows mutations
RT   related to myeloma patients at relapse with major hits in the DNA
RT   regulation and repair pathways.";
RL   J. Hematol. Oncol. 11:137.1-137.13(2018).
//